Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/178,368external-prioritypatent/US5187157A/en
Application filed by Du PontfiledCriticalDu Pont
Publication of MY104920ApublicationCriticalpatent/MY104920A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Peptides Or Proteins
(AREA)
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
PEPTIDES COMPRISING C-TERMINAL BORONIC ACID DERIVATIVES OF LYSINE, ORNITHINE, AND ARGININE, HOMOARGININE AND CORRESPONDING ISOTHIOURONIUM ANALOGS THEREOF, ARE REVERSIBLE INHIBITORS OF TRYPSIN-LIKE SERINE PROTEASES SUCH AS THROMBIN, PLASMA KALLIKREIN AND PLASMIN.
MYPI88000593A1987-06-051988-06-04Peptide boronic acid inhibitors of trypsin-like proteases.
MY104920A
(en)
Human plasma kallikrein and tissue kallikrein binding to a substrate based on the reactive site of a factor Xa inhibitor isolated from Bauhinia ungulata seeds